# Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

> **NCT02392078** · — · COMPLETED · sponsor: **Monteris Medical** · enrollment: 1153 (actual)

## Conditions studied

- Metastatic Brain Tumor
- Primary Brain Tumor
- Epileptic/Seizure Foci
- Movement Disorders

## Interventions

- **DEVICE:** NeuroBlate System

## Key facts

- **NCT ID:** NCT02392078
- **Lead sponsor:** Monteris Medical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 1153 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02392078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02392078, "Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02392078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*